SKT, BLRX, LPCN and ECOR among premarket gainers
- BySeeking Alpha-
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Buy | Sell | Sell | Sell |
| Technical Indicators | Strong Buy | Buy | Strong Sell | Strong Sell | Buy |
| Summary | Strong Buy | Buy | Strong Sell | Strong Sell | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 25.30 | 25.40 | 24.95 | 0.00 | 0.00% | 46.85M | Lagos | |||
| 7.95 | 7.95 | 7.85 | 0.00 | 0.00% | 23.30M | Lagos | |||
| 31.20 | 31.05 | 30.90 | -0.50 | -1.59% | 20.83M | Lagos | |||
| 7.10 | 7.10 | 6.85 | +0.05 | +0.71% | 26.50M | Lagos | |||
| 160.20 | 160.20 | 160.20 | -9.80 | -5.76% | 643.20K | Lagos | |||
| 2.65 | 3.00 | 2.65 | -0.25 | -8.62% | 4.05M | Lagos | |||
| 22.20 | 22.20 | 21.80 | +2.00 | +9.90% | 1.65M | Lagos | |||
| 7.40 | 7.40 | 7.40 | -0.05 | -0.67% | 442.57K | Lagos | |||
| 205.20 | 205.20 | 205.20 | -22.80 | -10.00% | 0.03K | Lagos | |||
| 0.67 | 0.00 | 0.00 | 0.00 | 0.00% | 20.36K | Lagos | |||
| 18.70 | 18.80 | 18.80 | +0.10 | +0.53% | 329.30K | Lagos | |||
| 4.65 | 4.65 | 4.65 | +0.240 | +5.44% | 162.29K | Lagos | |||
| 7.90 | 7.85 | 7.70 | +0.10 | +1.28% | 10.47M | Lagos | |||
| 0.51 | 0.00 | 0.00 | -0.04 | -7.55% | 12.46M | Lagos | |||
| 1.49 | 1.47 | 1.47 | +0.010 | +0.68% | 560.55K | Lagos |
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.